XML 12 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid In Capital [Member]
Accumulated Deficit [Member]
Beginning Balance at Dec. 31, 2022 $ (20,762) $ 1 $ 67,739 $ (88,502)
Beginning Balances (in shares) at Dec. 31, 2022   12,699,668    
Issuance of shares - equity line of credit, Shares   378,006    
Issuance of shares - equity line of credit 1,108   1,108  
Issuance of shares - commitment fee for equity line of credit, Shares   218,842    
Issuance of shares - commitment fee for equity line of credit 1,000   1,000  
Issuance of shares - prepaid forward contracts (As restated) 1,870   1,870  
Stock-based compensation 505   505  
Net loss (7,096)     (7,096)
Ending Balance at Mar. 31, 2023 (23,375) $ 1 72,222 (95,598)
Ending Balances (in shares) at Mar. 31, 2023   13,296,516    
Beginning Balance at Dec. 31, 2023 (13,870) $ 5 100,859 (114,734)
Beginning Balances (in shares) at Dec. 31, 2023   47,615,285    
Issuance of shares - conversion of convertible notes, Shares   12,697,792    
Issuance of shares - conversion of convertible notes 9,390 $ 1 9,389  
Issuance of shares - exercise of warrants, Shares   8,801,836    
Issuance of shares - exercise of warrants 3,960 $ 1 3,959  
Issuance of shares - equity offering, net of issue costs, Shares   6,304,545    
Issuance of shares - equity offering, net of issue costs 8,310 $ 1 8,309  
Stock-based compensation 434   434  
Net loss (12,697)     (12,697)
Ending Balance at Mar. 31, 2024 $ (4,473) $ 8 $ 122,950 $ (127,431)
Ending Balances (in shares) at Mar. 31, 2024   75,419,458